STAQ Pharma, Inc. recalls Hydromorphone HCL PF
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Labeling: Incorrect or Missing Lot and/or Exp Date
- Products
-
- Hydromorphone HCL PF
- Company
- STAQ Pharma, Inc.
- Where it was sold
-
Nationwide in the U.S.
Nationwide
- About this recall
- Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.